Oxysure Systems (OXYS) 0.7800 $OXYS
OxySure Systems Releases Financial Results for Quarter Ending June 30, 2014 - Video News Alert Hosted on InvestmentPitch.com
Newsfile Corp - Tue Aug 19, 9:37AM CDT
full story)
OxySure (OXYS) Reports Second Quarter 2014 Results
Marketwire - Fri Aug 15, 7:31AM CDT
OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"
, a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology today announced financial and operating results for the second quarter 2014.
OxySure (OXYS) to Host Second Quarter 2014 Financial Results Conference Call at 9:00 am ET on August 15, 2014
Marketwire - Tue Aug 12, 8:04AM CDT
OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company" , the medical device innovator of life-saving easy-to-use emergency oxygen solutions with its "oxygen from powder" technology today announced that it will hold a conference call at 9:00 am ET on Friday, August 15, 2014 to discuss its financial results for the three months ended June 30, 2014.
OxySure (OXYS) Announces New Milestone: Saves With Model 615 Exceeds 2,500
Marketwire - Fri Aug 08, 5:25AM CDT
OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company" , the medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology is excited to announce that the Company's flagship product, the OxySure Model 615 has achieved a new milestone regarding its successful use. The estimated number of successful saves with the use of Model 615 in medical emergencies has exceeded 2,500. OxySure's Model 615 is a lifesaving technology and is the world's leading emergency oxygen device for lay person use.
OxySure (OXYS) Announces Corporate Update
Marketwire - Wed Jul 30, 8:03AM CDT
OxySure Systems, Inc. (OTCQB: OXYS), ("OxySure," or the "Company" , the medical device innovator of life-saving easy-to-use emergency oxygen solutions with its "oxygen from powder" technology, announced today the release of a corporate update as presented by OxySure's CEO Julian Ross.
OxySure (OXYS) Receives Economic Incentive from City of Frisco
Marketwire - Wed Jul 09, 8:03AM CDT
OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company" , a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology is pleased to announce that the Company has earned an economic incentive from the City of Frisco through the Frisco Economic Development Corporation ("FEDC" .
OxySure (OXYS) Announces First Australian Approval
Marketwire - Tue Jun 24, 8:03AM CDT
OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company" , a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology is pleased to announce that the first of two approvals was received from the Therapeutic Goods Administration ("TGA" in Australia. The TGA approved the OxySure Model 615 cartridge for commercialization in Australia as a medical device under Class IIa with effect from June 2, 2014.
90 Million Patients With Life Threatening Respiratory Disease Need Medical Oxygen Right Now
GlobeNewswire - Wed Apr 02, 9:03AM CDT
According to the World Health Organisation (WHO), 28% of European adults smoke - compared with 18% in the U.S. Tobacco-related illnesses cause 16% of deaths in Europe, compared with 12% globally. Approximately 250,000 people die each year in Europe because of asthma and other respiratory diseases.
OxySure (OXYS) Announces CE Mark Approval for OxySure Model 615 Portable Emergency Oxygen Device
Marketwire - Wed Apr 02, 8:04AM CDT
OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company" , a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology is pleased to announce its OxySure Model 615 portable emergency oxygen device has received CE Mark approval, a critical step toward launching this unique product into the thirty countries belonging to the European Economic Area (EEA).
OxySure Systems (OXYS) Announces Investor Update on Annual Report
Marketwire - Mon Mar 31, 3:11PM CDT
OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company" , the medical device innovator of life-saving easy-to-use emergency oxygen solutions with its "oxygen from powder" technology today provided an investor update regarding the Company's expected reporting timeline for its annual report for the year ending December 31, 2013.
OxySure Systems (OXYS) to Present at Taglich Brothers 11th Annual Small Cap Equity Conference
Marketwire - Thu Mar 27, 8:15AM CDT
OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company" , the medical device innovator of life-saving easy-to-use emergency oxygen solutions with its "oxygen from powder" technology today announced that CEO Julian T. Ross will present at the Taglich Brothers 11th Annual Small Cap Equity Conference to be held on Tuesday, May 6, 2014 at the New York Athletic Club, 180 Central Park South in New York City. To register for the conference please click here: https://www.meetmax.com/sched/event_24749/inv...g_new.html ?cmd=register&event_id=24749
OxySure's Improving Financials & Operational Milestones Paint a Bullish Picture
ACCESSWIRE - Mon Mar 10, 8:01AM CDT
Whitefish, MT / March 10, 2014 / The healthcare industry has been attracting record amounts of capital in 2014, driven by biotechnology and pharmaceutical companies bringing new products to market. In fact, more than half of all money flowing into U.S. sector-focused ETFs, or $4.06 billion through February 28th, was placed in healthcare ETFs, according to data compiled by Bloomberg.
OxySure CEO Provides Shareholders With a "State of the Union" Communication
Marketwire Canada - Mon Mar 03, 8:20AM CST
OxySure Systems, Inc. (OTCQB: OXYS), ("OxySure," or the "Company" , the medical device innovator of life-saving easy-to-use emergency oxygen solutions with its "oxygen from powder" technology, announced today the release of a company overview as presented by OxySure's CEO Julian Ross.
Medical Device Innovator OxySure Systems Summarizes Recent Corporate Activities - Video News Alert Summary Hosted on InvestmentPitch.com
Newsfile Corp - Wed Feb 19, 10:18AM CST
full story)
Medical Device Innovator OxySure Systems (OTCQB:OXYS) Summarizes Recent Corporate Activities - Video News Alert Summary Hosted on InvestmentPitch.com
Thomson Reuters ONE - Wed Feb 19, 9:32AM CST
Vancouver, BC, February19, 2014 - OxySure Systems (OTCQB:OXYS) a medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology, has recent corporate activities summarized in a video by InvestmentPitch. The company owns numerous issued patents and patents pending on this technology which makes the provision of emergency oxygen safer, more accessible and easier to use than traditional oxygen provision systems.
Bringing Oxygen from First Response to Public Places
ACCESSWIRE - Tue Feb 18, 8:56AM CST
Emergency oxygen can help improve hypoxia - or insufficient oxygen reaching the cells - and reduce pain and breathing discomfort during breathing and cardiac emergencies. In a 2008 audit of oxygen use in ambulances and emergency departments in the U.K., researchers found that oxygen use in ambulances is very common at 2.2 million episodes each year.
OxySure De-Leverages to Improve Shareholder Value and Prepares for an Uplisting
ACCESSWIRE - Mon Feb 03, 9:38AM CST
OxySure Systems Inc. (OTCBB: OXYS), a medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology, recently announced that it removed approximately $967,609 of claimed indebtedness from its balance sheet by converting notes and other indebtedness to restricted common stock at above-market conversion prices of between $0.76 and $1.50 per share.
OxySure Systems (OXYS) to Present at SeeThruEquity Microcap Investor Conference
Marketwire - Mon Feb 03, 8:25AM CST
OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company" , the medical device innovator of life-saving easy-to-use emergency oxygen solutions with its "oxygen from powder" technology today announced that CEO Julian T. Ross will present at the SeeThruEquity Microcap Investor Conference on Thursday, February 6, 2014 at 2:30 pm EST. The Conference will be held at Convene Midtown East (730 Third Avenue) in midtown Manhattan, New York.
OxySure Systems (OXYS) Announces Investor Update Conference Call
Marketwire - Fri Jan 31, 8:25AM CST
OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company" , the medical device innovator of life-saving easy-to-use emergency oxygen solutions with its "oxygen from powder" technology today announced that the Company will host a conference call to update shareholders and other interested parties on Tuesday, February 4, 2014 at 10:30 a.m. Central Time - 11:30 a.m. Eastern Time. Julian T. Ross, Chief Executive Officer and President, will provide a brief update and overview.
S&P Capital IQ Initiates Coverage on OxySure Systems, Inc. in S&P Capital IQ Factual Stock Reports
PR Newswire - Tue Jan 28, 8:36AM CST
S&P Capital IQ announced today that it has commenced Standard & Poor's Factual Stock Report coverage on OxySure Systems, Inc.
OxySure Systems Releases Financial Results for Quarter Ending June 30, 2014 - Video News Alert Hosted on InvestmentPitch.com
Newsfile Corp - Tue Aug 19, 9:37AM CDT
full story)
OxySure (OXYS) Reports Second Quarter 2014 Results
Marketwire - Fri Aug 15, 7:31AM CDT
OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"
, a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology today announced financial and operating results for the second quarter 2014. OxySure (OXYS) to Host Second Quarter 2014 Financial Results Conference Call at 9:00 am ET on August 15, 2014
Marketwire - Tue Aug 12, 8:04AM CDT
OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"
, the medical device innovator of life-saving easy-to-use emergency oxygen solutions with its "oxygen from powder" technology today announced that it will hold a conference call at 9:00 am ET on Friday, August 15, 2014 to discuss its financial results for the three months ended June 30, 2014. OxySure (OXYS) Announces New Milestone: Saves With Model 615 Exceeds 2,500
Marketwire - Fri Aug 08, 5:25AM CDT
OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"
, the medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology is excited to announce that the Company's flagship product, the OxySure Model 615 has achieved a new milestone regarding its successful use. The estimated number of successful saves with the use of Model 615 in medical emergencies has exceeded 2,500. OxySure's Model 615 is a lifesaving technology and is the world's leading emergency oxygen device for lay person use. OxySure (OXYS) Announces Corporate Update
Marketwire - Wed Jul 30, 8:03AM CDT
OxySure Systems, Inc. (OTCQB: OXYS), ("OxySure," or the "Company"
, the medical device innovator of life-saving easy-to-use emergency oxygen solutions with its "oxygen from powder" technology, announced today the release of a corporate update as presented by OxySure's CEO Julian Ross. OxySure (OXYS) Receives Economic Incentive from City of Frisco
Marketwire - Wed Jul 09, 8:03AM CDT
OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"
, a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology is pleased to announce that the Company has earned an economic incentive from the City of Frisco through the Frisco Economic Development Corporation ("FEDC" . OxySure (OXYS) Announces First Australian Approval
Marketwire - Tue Jun 24, 8:03AM CDT
OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"
, a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology is pleased to announce that the first of two approvals was received from the Therapeutic Goods Administration ("TGA" in Australia. The TGA approved the OxySure Model 615 cartridge for commercialization in Australia as a medical device under Class IIa with effect from June 2, 2014. 90 Million Patients With Life Threatening Respiratory Disease Need Medical Oxygen Right Now
GlobeNewswire - Wed Apr 02, 9:03AM CDT
According to the World Health Organisation (WHO), 28% of European adults smoke - compared with 18% in the U.S. Tobacco-related illnesses cause 16% of deaths in Europe, compared with 12% globally. Approximately 250,000 people die each year in Europe because of asthma and other respiratory diseases.
OxySure (OXYS) Announces CE Mark Approval for OxySure Model 615 Portable Emergency Oxygen Device
Marketwire - Wed Apr 02, 8:04AM CDT
OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"
, a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology is pleased to announce its OxySure Model 615 portable emergency oxygen device has received CE Mark approval, a critical step toward launching this unique product into the thirty countries belonging to the European Economic Area (EEA). OxySure Systems (OXYS) Announces Investor Update on Annual Report
Marketwire - Mon Mar 31, 3:11PM CDT
OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"
, the medical device innovator of life-saving easy-to-use emergency oxygen solutions with its "oxygen from powder" technology today provided an investor update regarding the Company's expected reporting timeline for its annual report for the year ending December 31, 2013. OxySure Systems (OXYS) to Present at Taglich Brothers 11th Annual Small Cap Equity Conference
Marketwire - Thu Mar 27, 8:15AM CDT
OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"
, the medical device innovator of life-saving easy-to-use emergency oxygen solutions with its "oxygen from powder" technology today announced that CEO Julian T. Ross will present at the Taglich Brothers 11th Annual Small Cap Equity Conference to be held on Tuesday, May 6, 2014 at the New York Athletic Club, 180 Central Park South in New York City. To register for the conference please click here: https://www.meetmax.com/sched/event_24749/inv...g_new.html ?cmd=register&event_id=24749 OxySure's Improving Financials & Operational Milestones Paint a Bullish Picture
ACCESSWIRE - Mon Mar 10, 8:01AM CDT
Whitefish, MT / March 10, 2014 / The healthcare industry has been attracting record amounts of capital in 2014, driven by biotechnology and pharmaceutical companies bringing new products to market. In fact, more than half of all money flowing into U.S. sector-focused ETFs, or $4.06 billion through February 28th, was placed in healthcare ETFs, according to data compiled by Bloomberg.
OxySure CEO Provides Shareholders With a "State of the Union" Communication
Marketwire Canada - Mon Mar 03, 8:20AM CST
OxySure Systems, Inc. (OTCQB: OXYS), ("OxySure," or the "Company"
, the medical device innovator of life-saving easy-to-use emergency oxygen solutions with its "oxygen from powder" technology, announced today the release of a company overview as presented by OxySure's CEO Julian Ross. Medical Device Innovator OxySure Systems Summarizes Recent Corporate Activities - Video News Alert Summary Hosted on InvestmentPitch.com
Newsfile Corp - Wed Feb 19, 10:18AM CST
full story)
Medical Device Innovator OxySure Systems (OTCQB:OXYS) Summarizes Recent Corporate Activities - Video News Alert Summary Hosted on InvestmentPitch.com
Thomson Reuters ONE - Wed Feb 19, 9:32AM CST
Vancouver, BC, February19, 2014 - OxySure Systems (OTCQB:OXYS) a medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology, has recent corporate activities summarized in a video by InvestmentPitch. The company owns numerous issued patents and patents pending on this technology which makes the provision of emergency oxygen safer, more accessible and easier to use than traditional oxygen provision systems.
Bringing Oxygen from First Response to Public Places
ACCESSWIRE - Tue Feb 18, 8:56AM CST
Emergency oxygen can help improve hypoxia - or insufficient oxygen reaching the cells - and reduce pain and breathing discomfort during breathing and cardiac emergencies. In a 2008 audit of oxygen use in ambulances and emergency departments in the U.K., researchers found that oxygen use in ambulances is very common at 2.2 million episodes each year.
OxySure De-Leverages to Improve Shareholder Value and Prepares for an Uplisting
ACCESSWIRE - Mon Feb 03, 9:38AM CST
OxySure Systems Inc. (OTCBB: OXYS), a medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology, recently announced that it removed approximately $967,609 of claimed indebtedness from its balance sheet by converting notes and other indebtedness to restricted common stock at above-market conversion prices of between $0.76 and $1.50 per share.
OxySure Systems (OXYS) to Present at SeeThruEquity Microcap Investor Conference
Marketwire - Mon Feb 03, 8:25AM CST
OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"
, the medical device innovator of life-saving easy-to-use emergency oxygen solutions with its "oxygen from powder" technology today announced that CEO Julian T. Ross will present at the SeeThruEquity Microcap Investor Conference on Thursday, February 6, 2014 at 2:30 pm EST. The Conference will be held at Convene Midtown East (730 Third Avenue) in midtown Manhattan, New York. OxySure Systems (OXYS) Announces Investor Update Conference Call
Marketwire - Fri Jan 31, 8:25AM CST
OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"
, the medical device innovator of life-saving easy-to-use emergency oxygen solutions with its "oxygen from powder" technology today announced that the Company will host a conference call to update shareholders and other interested parties on Tuesday, February 4, 2014 at 10:30 a.m. Central Time - 11:30 a.m. Eastern Time. Julian T. Ross, Chief Executive Officer and President, will provide a brief update and overview. S&P Capital IQ Initiates Coverage on OxySure Systems, Inc. in S&P Capital IQ Factual Stock Reports
PR Newswire - Tue Jan 28, 8:36AM CST
S&P Capital IQ announced today that it has commenced Standard & Poor's Factual Stock Report coverage on OxySure Systems, Inc.
